Mayne Pharma has moved to reassure staff and investors after media reports suggested its Salisbury manufacturing site in South Australia could be at risk of closure if its proposed merger with US company Cosette Pharmaceuticals goes ahead.
Mayne Pharma responds to reports on the future of Adelaide manufacturing site
September 8, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
The challenge is for our gatekeepers. Can they see beyond the gate?
October 3, 2025 - - Latest News -
Trump administration links MFN and lower prices to faster FDA approvals
October 3, 2025 - - Latest News -
Vertex appoints Elisha Whitfield as senior country manager for Australia and New Zealand
October 2, 2025 - - Latest News -
Race Oncology uncovers novel anticancer mechanism for bisantrene
October 2, 2025 - - Australian Biotech -
Mark Butler announces boost for clinical trial reform, after years of delay
October 2, 2025 - - Latest News -
Pharmac moves to ease access to HIV medicines in New Zealand
October 2, 2025 - - Latest News -
If the UK has blinked on pharmaceutical pricing, Australia might have to pay attention
October 2, 2025 - - Latest News